Clinical Trial Update: Growth Response in Girls With Turner Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating growth response in girls with Turner syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Genetic Disorder, Turner Syndrome | Phase 4 | Status: COMPLETED